US 12,465,629 B2
Prevention and treatment of organ injuries
Ching-Pong Mak, Shanghai (CN); Fashu Ma, Shanghai (CN); Dong Xiao, Shanghai (CN); Michael Peel, Shanghai (CN); and Hans Fliri, Shanghai (CN)
Assigned to Farsight Medical Technology (Shanghai) Co., Ltd., Shanghai (CN)
Appl. No. 17/995,992
Filed by Farsight Medical Technology (Shanghai) Co., Ltd., Shanghai (CN)
PCT Filed Apr. 15, 2021, PCT No. PCT/CN2021/087501
§ 371(c)(1), (2) Date Oct. 12, 2022,
PCT Pub. No. WO2021/209003, PCT Pub. Date Oct. 21, 2021.
Claims priority of application No. PCT/CN2020/084820 (WO), filed on Apr. 15, 2020; and application No. PCT/CN2021/081574 (WO), filed on Mar. 18, 2021.
Prior Publication US 2023/0181680 A1, Jun. 15, 2023
Int. Cl. A61K 38/13 (2006.01); A61K 45/06 (2006.01); A61P 11/00 (2006.01)
CPC A61K 38/13 (2013.01) [A61K 45/06 (2013.01); A61P 11/00 (2018.01)] 20 Claims
 
1. A method for the prevention and/or treatment of an organ injury or a condition associated with an organ injury in a subject diagnosed with, or suffering from an infection, wherein the method comprises administering to said subject Compound I, or a pharmaceutically acceptable salt thereof

OG Complex Work Unit Chemistry